Skip to main content
. 2020 Nov 23;10(2):LMT44. doi: 10.2217/lmt-2020-0024

Figure 2. . Progression-free survival (in months) by neutrophil-to-lymphocyte ratio (high vs low) at baseline.

Figure 2. 

NLR: Neutrophil-to-lymphocyte ratio